Behçet's syndrome

British Journal of Ophthalmology

Volumn 87, Issue 4, 2003, Pages 381-382

  Stanford, M R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; PREDNISOLONE; RECOMBINANT ALPHA2A INTERFERON;

AUTOIMMUNE DISEASE; BEHCET DISEASE; DEPRESSION; DRUG MEGADOSE; EDITORIAL; FLU LIKE SYNDROME; HAIR LOSS; HUMAN; LEUKOPENIA; PRIORITY JOURNAL; PRURITUS; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; THYROIDITIS; UVEITIS; VISUAL IMPAIRMENT;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; BEHCET SYNDROME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-ALPHA; MALE; PROGNOSIS; TUMOR NECROSIS FACTOR-ALPHA; VISION DISORDERS;

EID: 0037383647     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.4.381     Document Type: Editorial

References (6)

1. Muhaya M, Lightman S, Ikeda E, et al. Behçet's disease in Japan and Great Britain. Ocular Immunol Inflam 2000;8:141-8.
2. Alpsoy E, Durusoy C, Yilmaz E, et al. Interferon alfa-2a in the treatment of Behçet's disease: a randomised, placeobo controlled and double-blind study. Arch Dermatol 2002;138:467-71.
3. Hasan A, Fortune F, Wilson K, et al. Role of γδ T cells in the pathogenesis and diagnosis of Behçet's disease Lancet 1996;347:789-94.
4. Sfikakis PP, Theodossiadis PG, Katsiari CG, et al. Effect of infliximab on sight-threatening panuveitis in Behçet's disease. Lancet 2001;358:295-6.
5. Robertson LP, Hickling P. Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab. Rheumatology 2001;40:473-4.
6. Travis SP, Czajkowski M, McGovern DP, et al. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody. Gut 2001;49:725-8.